| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Farrell Michael J. | Director | 345 E. MAIN STREET, WARSAW | /s/ Matthew R. St. Louis, Attorney-in-Fact for Michael J. Farrell (power of attorney previously filed) | 02 Jun 2025 | 0001485164 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ZBH | Phantom Stock Units | Award | $0 | +810 | +5.2% | $0.000000 | 16,428 | 29 May 2025 | Common Stock | 810 | $92.54 | Direct | F1, F2, F3, F4 |
| transaction | ZBH | Restricted Stock Units | Award | $0 | +1,405 | +13% | $0.000000 | 12,240 | 29 May 2025 | Common Stock | 1,405 | Direct | F2, F5, F6 |
| Id | Content |
|---|---|
| F1 | The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. |
| F2 | The Conversion or Exercise Price of Derivative Security is 1-for-1. |
| F3 | These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. |
| F4 | Includes 36.578 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
| F5 | The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. |
| F6 | Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. |